"10.1371_journal.pone.0083255","plos one","2013-12-17T00:00:00Z","Muzaffer Kaser; Fruzsina Soltesz; Phil Lawrence; Sam Miller; Chris Dodds; Rodney Croft; Robert B Dudas; Rashid Zaman; Emilio Fernandez-Egea; Ulrich MÃ¼ller; Anna Dean; Edward T Bullmore; Pradeep J Nathan","Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Bahcesehir University, Istanbul, Turkey; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; GlaxoSmithKline, Clinical Unit Cambridge, Medicines Discovery and Development, Cambridge, United Kingdom; Department of Psychology, University of Wollongong, Wollongong, Australia; Cambridge and Peterborough NHS Foundation Trust, United Kingdom; South Essex Partnership NHS Foundation Trust, United Kingdom; Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; School of Psychology and Psychiatry, Monash University, Melbourne, Australia; Neuroscience Discovery Medicine, UCB Pharma, Brussels, Belgium","Conceived and designed the experiments: PJN ETB. Performed the experiments: PL CMD AD RBD. Analyzed the data: SRM MK FS PJN. Contributed reagents/materials/analysis tools: RBD RZ EF UM. Wrote the manuscript: MK FS RC PJN.","Authors ETB, FS, CD, PL, SM are employees of GSK and hold shares in the company. Author PJN is a former employee of GSK and current employee of UCB Pharma, Belgium. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Muzaffer Kaser","MK",13,TRUE,2,4,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
